Potential disease modifying osteoarthritis candidate is phase II ready More: Merck KGaA out-licenses osteoarthritis programme to Novartis Source: News
read moreGovernment has placed first order for one million tests More: UK inks deal with Abingdon Health for rapid COVID-19 antibody tests Source: News
read morePfizer-BioNTech, Regeneron sued for patent infringement with COVID-19 products aliu Tue, 10/06/2020 – 11:04 More: Pfizer-BioNTech, Regeneron sued for patent infringement with COVID-19 products Source: fierce
read moreAmid White House feud, FDA raises vaccine rules that would nix a pre-election COVID shot esagonowsky Tue, 10/06/2020 – 10:59 More: Amid White House feud, FDA raises vaccine rules that would nix a pre-election COVID shot Source: fierce
read moreJust days after buyout notice, AMAG faces FDA push to withdraw premature-birth med Makena kblankenship Tue, 10/06/2020 – 10:40 More: Just days after buyout notice, AMAG faces FDA push to withdraw premature-birth med Makena Source: fierce
read moreOxford Biomedica earns U.K. nod for 4th manufacturing suite to boost COVID-19 production kblankenship Tue, 10/06/2020 – 09:06 More: Oxford Biomedica earns U.K. nod for 4th manufacturing suite to boost COVID-19 production Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals